CFM
ANRO icon

Cornerstone Financial Management’s Alto Neuroscience ANRO Stock Holding History

Cornerstone Financial Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82K Hold
69
– – ﹤0.01% 876
2026
Q1 		$1.55K Hold
69
– – ﹤0.01% 822
2025
Q4 		$1.23K Buy
+69
New +$869 ﹤0.01% 845

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Cornerstone Financial Management's ANRO Position: Q2 2026 in Review

Cornerstone Financial Management held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 69 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Cornerstone Financial Management first reported a position in ANRO in Q4 2025 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Cornerstone Financial Management held 69 shares of Alto Neuroscience worth $1.82K as of Q2 2026.
  • Cornerstone Financial Management left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #876 holding.
  • Cornerstone Financial Management first reported a position in Alto Neuroscience in Q4 2025 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.